Motion Sickness on Astrolabe's Vessel (SICKVEST)

Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe

Sea sickness syndrome is present for 80% of persons on board when the boat rotation missions Astrolabe, sometimes there is a risk of very significant dehydration. A special unit specialized in the fundamental study of the vestibular system (inner ear), sensory organ at the base of visual-vestibular conflict inducing this syndrome, also provides medical support for parabolic flights (flight reproducing weightlessness) where this syndrome is strongly present. The goal of the study is to assess the frequency of occurrence of this sea sickness syndrome on the Astrolabe, to understand the triggers (type of boat movements, personality traits, anxiety / stress) without changing habits on board for those on board taking a antinaupathique treatment given by the ship's doctor. This study will be done in collaboration between INSERM U 1075 (France) and the Laboratory of military research VIPER specialized in extreme environments (Belgium). The ultimate goal will be to provide the best recommendations and the best treatment regimen to alleviate as best as possible the symptoms of people on board of the Astrolabe so scientists on board can perform their work.

Study Overview

• Status: Completed
• Conditions: Sea Sickness
• Intervention / Treatment: Other: sea sickness questionnaires

Detailed Description

Background: The objectives were to assess the prevalence, severity, medication taken and to look for predictive factors, in order to better identify characteristics of passengers at risk of motion sickness during transport scientists travelling from Hobart in Tasmania to the French polar stations in Antarctica.

Methods: Two hundred and thirty-nine passengers were surveyed over 4 years with 4 round trips per year using Motion Sickness Susceptibility Questionnaire (MSSQ), Simulator Sickness Questionnaire (SSQ), state-trait anxiety test (STAI-Trait and STAI-State), and general parameters (age, gender, number of trips, jet-lag, direction of the trip), medication, calculation of the distance of each passenger's cabin to the Centre of Gravity (CoG.).

• Study Type: Observational
• Enrollment (Actual): 147

Contacts and Locations

Study Locations

• France
  • Caen, France, 14033
    • CAEN University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Astrolabe passengers

Description

Inclusion Criteria:

• participant aged of 18 or older but younger than 70 who received their medical ability to travel to Terre Adélie or making a research cruise aboard the Astrolabe
• particpant signing the informed consent.

Exclusion Criteria:

• none

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Motion Sickness susceptibilty questionnaire (fMSSQ)	Sensitivity of motion sickness	day 1 to day 10
STAY-YA questionnaire	anxiety	day 1 to day 10
STAY-YB questionnaire	anxiety	day 1 to day 10
Vis-Morgen Questonnaire about sleeping	Subjective sleep scoring	day 1 to day 10
Fatigue questionnaire	Tiredness	day 1 to day 10
Dietary intake survey	food intake	day 1 to day 10

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
type of movement from the ship using use the data from the Dynamic Positioning System on board	boat motion	baseline and every day up to 10 days
data from individual actigraphs worn by the participants	this will allow to quantify particpant's movements related to the ship movement	baseline and every day up to 10 days
personnality questionnaire (OCEAN)	Personnality	baseline and every day up to 10 days
anxiety questionnaire (STAY).	anxiety	baseline and every day up to 10 days
treatment taken (international denomination and dose)	treatment taken by subject for motion sickness	baseline and every day up to 6 days

Collaborators and Investigators

• Sponsor: University Hospital, Caen
• Investigators: Principal Investigator: stephane Besnard, MD, CaenHU

Study record dates

Study Major Dates

• Study Start: October 1, 2014
• Primary Completion (Actual): December 1, 2017
• Study Completion (Actual): December 1, 2018

Study Registration Dates

• First Submitted: September 20, 2016
• First Submitted That Met QC Criteria: September 20, 2016
• First Posted (Estimate): September 22, 2016

Study Record Updates

• Last Update Posted (Actual): February 15, 2022
• Last Update Submitted That Met QC Criteria: January 31, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Motion Sickness
• Other Study ID Numbers: 14-153

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO